SeaCrest Wealth Management LLC Has $1.04 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SeaCrest Wealth Management LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,982 shares of the medical equipment provider’s stock after purchasing an additional 42 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in Intuitive Surgical were worth $1,035,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA acquired a new stake in Intuitive Surgical during the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC raised its stake in Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares during the period. FMR LLC raised its stake in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB raised its stake in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the period. Finally, State Street Corp raised its stake in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on ISRG. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Truist Financial boosted their price target on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, December 18th. Piper Sandler restated an “overweight” rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Leerink Partners boosted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $580.11 on Thursday. The firm has a market cap of $206.62 billion, a price-to-earnings ratio of 93.27, a P/E/G ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $355.17 and a fifty-two week high of $584.60. The firm has a fifty day moving average price of $537.05 and a two-hundred day moving average price of $496.50.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 in the last quarter. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.